SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-188616
Filing Date
2014-05-08
Accepted
2014-05-08 07:01:57
Documents
14
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d695003d10q.htm 10-Q 389058
2 EX-10.53 d695003dex1053.htm EX-10.53 359418
3 EX-10.54 d695003dex1054.htm EX-10.54 46331
4 EX-18.1 d695003dex181.htm EX-18.1 3330
5 EX-31.1 d695003dex311.htm EX-31.1 9806
6 EX-31.2 d695003dex312.htm EX-31.2 9831
7 EX-32.1 d695003dex321.htm EX-32.1 6860
14 GRAPHIC g695003g15y55.jpg GRAPHIC 138067
  Complete submission text file 0001193125-14-188616.txt   5843996

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT vnda-20140331.xml EX-101.INS 644330
9 XBRL TAXONOMY EXTENSION SCHEMA vnda-20140331.xsd EX-101.SCH 60018
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnda-20140331_cal.xml EX-101.CAL 76529
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnda-20140331_def.xml EX-101.DEF 377964
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnda-20140331_lab.xml EX-101.LAB 411397
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnda-20140331_pre.xml EX-101.PRE 451787
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34186 | Film No.: 14822912
SIC: 2834 Pharmaceutical Preparations